Existing literature has also failed to establish an association between GLP-1 agonist and increased postoperative nausea and vomiting
Wiviott, S
Hng dn cch b sung creatine hiu qu nht Th By, 10/06/2023 Creatine l mt trong nhng cht b sung ph bin nht dnh cho VV th hnh, ngi tp gym v c nhng ngi thng xuyn chi th thao
Al-Kharobi, H., El-Gendy, R., Devine, D
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: a phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes
GLP-1 stimulates insulin release in response to glucose, suppresses the hormone glucagon that raises blood sugar, slows gastric emptying, and reduces appetite by acting on hunger centres in the brain